MELVILLE, N.Y.--(BUSINESS WIRE)--Feb. 6, 2006--OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) today announces two changes in its corporate governance designed to allow stockholders a stronger voice concerning major strategic initiatives the Company may choose to undertake in the future.
